| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/19/1992 | CN1017901B Process for the preparation of antipsychotic fused-ring pyridnylpiperazine derivatives |
| 08/18/1992 | US5140044 Antitumor and -carcinogenic agents; protein kinase C inhibitors |
| 08/18/1992 | US5140037 Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists |
| 08/18/1992 | US5140015 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents |
| 08/18/1992 | US5140012 Method for preventing onset of restenosis after angioplasty employing pravastatin |
| 08/18/1992 | CA1306461C Benzhydryloxyethylpiperazine derivatives, processes for their preparation and pharmaceutical compositions in which they are present |
| 08/17/1992 | WO1992014714A1 Substituted pyridinones and pyrimidinones as angiotensin ii antagonists |
| 08/14/1992 | WO1992014734A1 Imidazopyridine paf/h1 antagonists |
| 08/14/1992 | WO1992014725A1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity |
| 08/14/1992 | CA2101160A1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity |
| 08/13/1992 | WO1992013856A1 5-heteroyl indole derivatives |
| 08/13/1992 | CA2101521A1 5-heteroyl indole derivatives |
| 08/12/1992 | EP0498723A1 Nitrogen containing bicycle compounds, method for their preparation, their use as pharmaceutical and compositions containing them |
| 08/12/1992 | EP0498721A1 N-substituted quinoline derivatives, process for their preparation, intermediates obtained, their use as pharmaceuticals and pharmaceutical compositions containing them |
| 08/12/1992 | EP0498718A1 Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydro-pyridine-derivatives as free radical scavengers |
| 08/12/1992 | EP0498665A1 Hydroxamic acids derivatives, process for their preparation and use thereof |
| 08/12/1992 | EP0498590A1 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes |
| 08/12/1992 | EP0498470A2 An injectable pharmaceutical composition for the protection of tissue damaged by ischemia |
| 08/12/1992 | EP0498466A1 Indazole-3-carboxamide and -3-carboxylic acid derivatives |
| 08/12/1992 | EP0498334A1 2,4- and 2,5-bis-(tetrazolyl)pyridines, process for their preparation and their use as medicines |
| 08/12/1992 | EP0498069A2 New use of peptide derivative |
| 08/12/1992 | EP0497915A1 hPTH (1-37) FRAGMENT, ITS PRODUCTION, DRUG CONTAINING IT AND ITS USE. |
| 08/12/1992 | EP0497910A1 Camptothecin analogs as potent inhibitors of human colorectal cancer |
| 08/12/1992 | EP0497888A1 Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid derivatives as inhibitors of pla 2? and lipoxygenase |
| 08/12/1992 | EP0497866A1 Gastrin releasing peptide receptor |
| 08/12/1992 | EP0497845A1 Bafilomycine macrolides for treatment of bone affecting diseases |
| 08/12/1992 | CA2060940A1 N-imidazolyl derivatives of substituted alkoxyimino tetrahydro-naphthalenes and chromans |
| 08/12/1992 | CA2060699A1 Gm-csf inhibiting oligopeptides |
| 08/12/1992 | CA2060107A1 Nitrogen heterocycles |
| 08/12/1992 | CA2060050A1 Heterocyclic derivatives |
| 08/11/1992 | US5138039 Diagnosis, therapy |
| 08/11/1992 | US5137928 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents |
| 08/11/1992 | US5137914 Vasodilation, anticoagulants, bronchodilator agents |
| 08/11/1992 | US5137913 Diaryl ether cyclic ethers |
| 08/11/1992 | US5137901 For binding 5-HT 1 receptors; treating central nervous system disorders |
| 08/11/1992 | US5137891 2',3' cyclic fused pyrazolopyrimidine type mevalonolactones |
| 08/11/1992 | US5137882 Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors |
| 08/11/1992 | US5137881 Anticholesterol, antilipemic agents |
| 08/11/1992 | US5137878 Composition and method for treatment of senile dementia |
| 08/10/1992 | CA2060954A1 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs |
| 08/08/1992 | WO1992013848A1 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives |
| 08/08/1992 | WO1992013831A1 Hydroxamic acid derivatives, process for their preparation and use thereof |
| 08/08/1992 | CA2101539A1 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives |
| 08/08/1992 | CA2100661A1 Hydroxamic acid derivatives, process for their preparation and use thereof |
| 08/08/1992 | CA2060843A1 N-substituted derivatives of quinoleine, process for their preparation, new intermediates obtaines, their application as drugs and pharmaceutical compositions containing them |
| 08/08/1992 | CA2060750A1 Bicyclic nitrogenated derivatives, process for their preparation, novel intermediates thus obtaines, their applications as drugs, and phamarceutical compositions containing them |
| 08/06/1992 | WO1992013095A1 Methods for treating tumor necrosis factor mediated diseases |
| 08/06/1992 | WO1992013074A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 08/06/1992 | WO1992012990A1 14,16β-ETHANO-15β,161 -CYCLO-14β-ESTRA-1,3,5(10)-TRIENES |
| 08/06/1992 | WO1992012986A1 Sphingoglycolipid |
| 08/06/1992 | WO1992012739A1 Depot formulations |
| 08/06/1992 | WO1992012710A1 Orally administerable drugs for the treatment of central dopamine deficiency conditions |
| 08/06/1992 | WO1992011037A3 Targeting of therapeutic agents using polysaccharides |
| 08/06/1992 | WO1992001675A3 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene b4 antagonist activity, their preparation and use in pharmaceutical compositions |
| 08/06/1992 | CA2100863A1 Adenosine kinase inhibitors |
| 08/06/1992 | CA2097424A1 Corticotropin releasing factor binding protein (crf-bp) |
| 08/06/1992 | CA2060622A1 2,4- and 2,5-bistetrazolylpyridines, a process for the preparation thereof and the use thereof as pharmaceuticals |
| 08/05/1992 | EP0497629A1 Heterocyclic amido prostaglandin analogs |
| 08/05/1992 | EP0497516A1 Substituted pyrrolo-fused 6-membered heterocycles as angiotensin II antagonists |
| 08/05/1992 | EP0497368A1 CNP analog peptides and their use |
| 08/05/1992 | EP0497341A2 Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccahride, for use as antiviral agent |
| 08/05/1992 | EP0497313A1 Allosamidin compounds and a process for production thereof |
| 08/05/1992 | EP0497258A2 Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer |
| 08/05/1992 | EP0497202A1 Polyamine thiols as radioprotective agents |
| 08/05/1992 | EP0497201A1 Tricyclic compounds and intermediates thereof |
| 08/05/1992 | EP0497150A1 Angiotensin II receptor blocking 2,3,6-substituted quinazolones |
| 08/05/1992 | EP0496973A2 Somatotropins with alterations in the alpha-helix 1 region, and combinations with other mutations |
| 08/05/1992 | EP0496833A1 BIOSYNTHETIC CONSTRUCTS OF TGF-$g(b) |
| 08/05/1992 | EP0261185B1 7-oxoprostacycline derivatives and process for their manufacture |
| 08/05/1992 | CN1017708B Method for preparation of pyrazolotriazine compounds |
| 08/04/1992 | US5136023 Genetically engineered; activity of human fibronectin |
| 08/04/1992 | US5135938 Leukotriene antagonists |
| 08/02/1992 | CA2059906A1 Heterocyclic amido prostaglandin analogs |
| 08/01/1992 | CA2060277A1 Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent |
| 07/31/1992 | WO1992013895A1 LOW-MOLECULAR SULPHATED POLY-β-2,6-FRUCTOFURANOSANES AND THEIR USE IN THE TREATMENT OF DEGENERATIVE ARTICULAR AILMENTS |
| 07/31/1992 | CA2101630A1 Niedermolekulare sulfatierte poly-.beta.-2,6-fructofuranosane und deren verwendung zur behandlung von degenerativen gelenkserkrankungen ( low molecular sulphated poly-.beta.-2,6 fructofuranosanes and their use in the treatment of degenerati e articular ailments) |
| 07/31/1992 | CA2060154A1 Angiotensin ii receptor blocking quinazolones |
| 07/31/1992 | CA2060055A1 Substituted pyrrolo-fused 6-membered heterocycles as angiotensin ii antagonists |
| 07/30/1992 | DE4102244A1 14,16ss-ethano-15ss, 16(pfeil hoch)1(pfeil hoch)-cyclo-14ss-estra-1,3,5(10)-triene 14,16ss-ethano-15SS, 16 (arrow up) 1 (arrow up) cyclo-14ss-estra-1,3,5 (10) -trienes |
| 07/30/1992 | DE4101873A1 Peroral applizierbare arzneiform zur behandlung zentraler dopaminmangelzustaende Orally administered drug form for treatment central dopaminmangelzustaende |
| 07/30/1992 | CA2060138A1 New use of the adenosine antagonist |
| 07/30/1992 | CA2035143A1 Compositions with enhanced penetration |
| 07/29/1992 | EP0496692A1 2-Methoxyphenylpiperazine derivatives |
| 07/29/1992 | EP0496691A1 Diphenylmethylpiperazine derivatives |
| 07/29/1992 | EP0496617A1 Adenosine kinase inhibitors |
| 07/29/1992 | EP0496548A1 Carbacyclin analogs |
| 07/29/1992 | EP0496520A1 Novel bone acting agents |
| 07/29/1992 | EP0496306A1 Process for the preparation of 3-amino-9,13b-dihydro-1H-dibenz-[c,f]imidazo[1,5-a]azepine hydrochloride |
| 07/29/1992 | EP0496237A2 N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept[b]indole |
| 07/29/1992 | EP0496222A1 Indole derivatives |
| 07/29/1992 | EP0496160A1 Synthetic conversion of bryostatin 2 into bryostatin 1 |
| 07/29/1992 | EP0495948A1 Process for the manufacture of quinoline derivatives |
| 07/29/1992 | EP0495893A1 Dopamine releasing protein |
| 07/29/1992 | EP0495889A1 IMINOMETHANODIBENZO(a,d)CYCLOHEPTENE DERIVATIVES AS NEUROPROTECTANT AGENTS |
| 07/29/1992 | EP0435996A4 Modified transforming growth factor -g(a) oligopeptides and pharmaceutical compositions thereof |
| 07/29/1992 | CN1063108A Trifluoromethylktone derivatives and processes for preparation thereof and use thereof |
| 07/29/1992 | CN1017626B Growth resulating factor for new cell |
| 07/28/1992 | US5134157 Trimethylcyclohexyl Pyroglutamate, Antilipemic Agents |
| 07/28/1992 | US5134155 Anticholesterol |
| 07/28/1992 | US5134149 Serotonin antagonist |